Employers Holdings Full Year 2022 Earnings EPS US1.78 - Yahoo Finance

SPHDF Stock  USD 9.42  0.00  0.00%   
Roughly 62% of Santhera Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Santhera Pharmaceuticals Holding pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Santhera Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Santhera Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Santhera Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Santhera daily returns and investor perception about the current price of Santhera Pharmaceuticals Holding as well as its diversification or hedging effects on your existing portfolios.
  
Employers Holdings Full Year 2022 Earnings EPS US1.78 Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Santhera Pharmaceuticals Fundamental Analysis

We analyze Santhera Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Santhera Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Santhera Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Earning

Price To Earning Comparative Analysis

Santhera Pharmaceuticals is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Santhera Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Santhera Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Santhera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Santhera Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Santhera Pharmaceuticals Related Equities

ANABAnaptysBio   6.50   
0%
100.0%
DSGNDesign Therapeutics   6.37   
0%
98.0%
LEXXLexaria Bioscience   2.06   
0%
31.0%
ACHLAchilles Therapeutics   0.88   
0%
13.0%
IVAInventiva   0.46   
0%
7.0%
IDYAIdeaya Biosciences   0.04   
1.0%
0%
KROSKeros Therapeutics   0.18   
2.0%
0%
GNFTGenfit   1.64   
25.0%
0%
GHRSGH Research   2.11   
32.0%
0%
ZVSAZyVersa Therapeutics   5.41   
83.0%
0%
BDRXBiodexa Pharmaceticals   5.45   
83.0%
0%
MGTXMeiraGTx Holdings   5.77   
88.0%
0%

Complementary Tools for Santhera Pink Sheet analysis

When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance